Indiana Biosciences Research Institute
The Indiana Biosciences Research Institute (IBRI) is an American nonprofit research and technology organization serving the state of Indiana.[1] The IBRI is the nation's first industry-led collaborative life sciences research institute.[2] Their work focuses on targeting diabetes, metabolic disease, and poor nutrition.[3]
Formation | May 1, 2013 |
---|---|
Type | Research Institute |
Headquarters | Indianapolis, Indiana |
Location |
|
Region served | Indiana |
Staff | 100 |
Website | http://indianabiosciences.org |
History
In 2012, pharmaceutical executive John C. Lechleiter from Eli Lilly & Company initially proposed the IBRI.[4][5] In 2013, Indiana governor Mike Pence announced the formation of the IBRI.[6] Pence later worked with life sciences leaders to secure $25 million in startup funds from the state.[7]
In 2015, the IBRI hired David Broecker as CEO.[8] In late 2015, the Indianapolis City-County Council approved $75 million to build a technology park called 16 Tech.[9] In 2016, the IBRI hired Rainer Fischer as Chief Scientific Officer.[10][11] In 2017, Governor Eric Holcomb reaffirmed the commitment made by his predecessor Mike Pence.[12][13][14]
Leadership
Appointees to the IBRI’s Board of Directors include:
- David Broecker, IBRI
- Wayne Burris, Roche Diagnostics
- Darren Carroll, Eli Lilly & Company
- Daniel Evans: Jr., Indiana University Health
- David Johnson, BioCrossroads and Central Indiana Corporate Partnership
- Dan Peterson, Cook Group
- Jon Serbousek, Mid-Tech Industry Advisor
- Bill Stephan, Indiana University
- Micah Vincent, State of Indiana
- Steve Webb, Dow AgroSciences
Appointees to the IBRI’s Scientific Advisory Board include:
- Nitesh Chawla, University of Notre Dame
- Christina Dann, Cook Regentec
- Suresh Garimella, Purdue University
- Brian Heald, Roche Diagnostics
- Michael Hiles, Cook Biotech
- Gary Krishnan, Eli Lilly & Company
- Jay McGill, Eli Lilly & Company
- Raghu Mirmira, IBRI
- Steve Webb, Dow AgroSciences
- Alan Wright, Roche Diagnostics
References
- Rudavsky, Shari (February 24, 2016). "New biosciences institute gets $100M". Indianapolis Star. Retrieved June 22, 2017.
- O'Malley, Chris (June 30, 2016). "Bioscience research institute creates a 'petri dish' for innovation". Crain Communications. Retrieved June 22, 2017.
- Audretsch, David B. (2015). The Oxford Handbook of Local Competitiveness. Oxford University Press. p. 409. ISBN 9780199993307.
- Lechleiter, John (March 31, 2015). "From hunting to farming, medicines development takes a big leap forward". Forbes. Retrieved June 22, 2017.
- Pogorelc, Deanna (May 30, 2013). "Eli Lilly, Roche, device makers collaborate on new public-private research institute in Indiana". MedCity News. Retrieved June 22, 2017.
- Pence, Mike (May 30, 2013). "Governor Pence Announces Indiana Biosciences Research Institute". YouTube. Retrieved June 22, 2017.
- Nather, David (July 16, 2016). "With Pence pick, Trump just made women's health a top-tier election issue". PBS. Retrieved June 22, 2017.
- Swiatek, Jeff (May 19, 2015). "New CEO of bioscience institute looks to hire researchers, raise millions". Indianapolis Star. Retrieved June 22, 2017.
- Eason, Brian (November 9, 2015). "City-County Council OKs $75M for Indianapolis tech park". USA Today. Retrieved June 22, 2017.
- Ober, Andy (October 4, 2016). "IBRI hires European bioscience giant". Inside INdiana Business. Retrieved June 22, 2017.
- Russell, John (April 1, 2017). "FOCUS: Biosciences institute's chief scientific officer aims to foster commercialization". Indianapolis Business Journal. Retrieved June 22, 2017.
- Redman, Mary-Rachel (January 16, 2017). "Roche CEO: IBRI Will Succeed Where Others Have Failed". Inside INdiana Business. Retrieved June 22, 2017.
- Lange, Kaitlin (April 21, 2017). "How Gov. Holcomb's priorities fared in the state budget". Indianapolis Star. Retrieved June 22, 2017.
- Heinz, Katie (January 5, 2017). "Governor-elect Eric Holcomb unveils 2017 legislative agenda". WRTV. Retrieved June 22, 2017.